According to a new study, T-cells — a type of white blood cell that is an essential part of the immune system — taken from the blood of recovered Covid-19 patients can help in the treatment of Covid-19 infected people.
Also read: Covid-19 incubation period can be 1 to 34 days: Study
The study, published in the journal Blood , stated that these cells need to be taken and multiplied in the lab so that they can effectively target proteins that are important for the virus to function.
Lead author of the study, Michael Keller, a paediatric immunology specialist at Children's National Hospital, said: "We found that many people who recover from Covid-19 have T-cells that recognise and target viral proteins of SARS-CoV-2, giving them immunity from the virus because those T-cells are primed to fight it."
He added: "This suggests that adoptive immunotherapy using convalescent T-cells to target these regions of the virus may be an effective way to protect vulnerable people, especially those with compromised immune systems due to cancer therapy or transplantation."
Also read: Don’t give up on plasma therapy, say researchers
The researchers involved in the Cellular Therapy Programme at Children's National hypothesised that the expanded group of Covid-19 virus-targeting T-cells could be infused into immuno-compromised patients. This can help patients to boost their immunity that can fight the virus.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.